ストックスクリーナーアプリを入手
8.43
1.86%
-0.16
前日終値:
$8.59
開ける：
$8.61
24時間の取引高:
3.33M
Relative Volume:
1.49
時価総額：
$2.64B
収益：
$493.67M
当期純損益:
$-104.69M
株価収益率:
-24.79
EPS:
-0.34
ネットキャッシュフロー:
$-31.51M
1週間 パフォーマンス:
-6.39%
1か月 パフォーマンス:
-8.27%
6か月 パフォーマンス:
-21.29%
1年 パフォーマンス:
-28.44%
1日の値動き範囲:
$8.36
$8.615
1週間の範囲:
$8.36
$9.08
52週間の値動き範囲:
$8.36
$12.65
Amicus Therapeutics Inc Stock (FOLD) Company Profile
名前
Amicus Therapeutics Inc
セクター
電話
(609) 662-2000
住所
47 HULFISH STREET, PRINCETON, NJ
FOLD を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
FOLD
Amicus Therapeutics Inc
|
8.43 | 2.64B | 493.67M | -104.69M | -31.51M | -0.34 |
|
VRTX
Vertex Pharmaceuticals Inc
|
492.69 | 131.41B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
637.36 | 72.26B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
589.15 | 35.93B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
268.46 | 34.75B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
267.39 | 28.24B | 3.81B | -644.79M | -669.77M | -6.24 |
Amicus Therapeutics Inc Stock (FOLD) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-12-13 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2024-09-06 | 開始されました | Jefferies | Buy |
| 2024-05-30 | 開始されました | Wells Fargo | Overweight |
| 2024-05-14 | アップグレード | Guggenheim | Neutral → Buy |
| 2023-12-19 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2022-09-09 | 開始されました | Morgan Stanley | Equal-Weight |
| 2022-04-13 | 再開されました | Goldman | Neutral |
| 2022-01-14 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2021-11-15 | アップグレード | Stifel | Hold → Buy |
| 2021-09-30 | アップグレード | JP Morgan | Neutral → Overweight |
| 2021-07-19 | 再開されました | BTIG Research | Buy |
| 2021-05-27 | 開始されました | Needham | Hold |
| 2021-05-21 | 開始されました | UBS | Buy |
| 2021-04-14 | アップグレード | Cantor Fitzgerald | Neutral → Overweight |
| 2021-03-02 | 開始されました | Stifel | Hold |
| 2021-02-12 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2021-02-12 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2020-12-28 | 再開されました | Cantor Fitzgerald | Overweight |
| 2020-12-10 | ダウングレード | Citigroup | Buy → Neutral |
| 2020-11-11 | 開始されました | Berenberg | Hold |
| 2020-06-17 | 開始されました | BTIG Research | Buy |
| 2020-02-04 | 再開されました | Cantor Fitzgerald | Overweight |
| 2019-11-12 | 繰り返されました | H.C. Wainwright | Buy |
| 2019-06-17 | 開始されました | H.C. Wainwright | Buy |
| 2019-06-05 | 繰り返されました | Cantor Fitzgerald | Overweight |
| 2019-04-05 | 開始されました | Janney | Buy |
| 2019-01-30 | 開始されました | Cantor Fitzgerald | Overweight |
| 2018-10-29 | 開始されました | Citigroup | Neutral |
| 2018-08-17 | ダウングレード | Chardan Capital Markets | Buy → Neutral |
| 2017-10-06 | 再開されました | Goldman | Neutral |
| 2017-09-13 | 繰り返されました | Chardan Capital Markets | Buy |
| 2017-08-10 | 繰り返されました | Chardan Capital Markets | Buy |
| 2017-01-24 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2016-05-18 | 開始されました | BofA/Merrill | Buy |
| 2016-04-14 | 開始されました | Robert W. Baird | Neutral |
| 2016-04-12 | 繰り返されました | Chardan Capital Markets | Buy |
| 2015-09-16 | ダウングレード | Chardan Capital Markets | Buy → Neutral |
| 2015-06-16 | 繰り返されました | Chardan Capital Markets | Buy |
すべてを表示
Amicus Therapeutics Inc (FOLD) 最新ニュース
Amicus Therapeutics (NASDAQ:FOLD) Sets New 12-Month LowHere's Why - MarketBeat
Fox Run Management L.L.C. Acquires 30,162 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat
Amicus Therapeutics (NASDAQ:FOLD) Trading Down 2.5%Time to Sell? - MarketBeat
Is Amicus Therapeutics (NASDAQ:FOLD) A Risky Investment? - Simply Wall St
Intech Investment Management LLC Has $1.18 Million Holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat
Pompe Disease Treatment Market Size in 7MM is expected to grow at - openPR
Amicus Therapeutics stock hits 52-week low at $8.54 By Investing.com - Investing.com UK
Semanteon Capital Management LP Purchases 43,288 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat
Pompe Disease Treatment Market reached US$ 1.39 billion in 2024 - openPR
Primecap Management Co. CA Sells 94,000 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat
Victory Capital Management Inc. Reduces Holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Shares Sold by Charles Schwab Investment Management Inc. - MarketBeat
Amicus Therapeutics (FOLD) Up 0.1% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio - Yahoo Finance
Connor Clark & Lunn Investment Management Ltd. Has $2.85 Million Stock Holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat
How to Take Advantage of moves in (FOLD) - Stock Traders Daily
Pompe Disease Treatment Market Size, Potential Scope 2033 By Key - openPR
Amicus Posts Preliminary 2024 Results, Issues 2025 Outlook - MSN
Great Lakes Advisors LLC Lowers Position in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat
Is Amicus Therapeutics Inc. (FOLD) the Best Nasdaq Stock Under $20 to Buy Now? - Insider Monkey
Amicus Therapeutics Is Very Attractive At Current Prices (Rating Upgrade) (NASDAQ:FOLD) - Seeking Alpha
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Shares Sold by Inceptionr LLC - MarketBeat
Amicus Therapeutics (NASDAQ:FOLD) Reaches New 52-Week LowTime to Sell? - MarketBeat
Pompe Disease Treatment Market Size in the 7MM is expected - openPR
Essex Investment Management Co. LLC Has $2.18 Million Stock Holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat
Amicus Therapeutics, Inc. (FOLD): Among the Stocks Under $10 With High Upside Potential - Insider Monkey
Amicus Therapeutics at Leerink Conference: Path to Profitability By Investing.com - Investing.com Canada
Amicus Therapeutics stock hits 52-week low at $8.78 By Investing.com - Investing.com Canada
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Sees Significant Drop in Short Interest - MarketBeat
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Oppenheimer Asset Management Inc. Trims Stock Holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - Defense World
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Shares Sold by Principal Financial Group Inc. - Defense World
Amicus Therapeutics, Inc. to Host Earnings Call - ACCESS Newswire
Amicus Therapeutics Inc (FOLD) 財務データ
収益
当期純利益
現金流量
EPS
0.39%
0.34%
大文字化:
|
ボリューム (24 時間):